Biosimilar Solutions Initiates Registrational Clinical Trial for Biosimilar Version Neulasta
13 avr. 2022 13h31 HE
|
OcyonBio (ocyonbio.com)
AGUADILLA, Puerto Rico, April 13, 2022 (GLOBE NEWSWIRE) -- OcyonBio, LLC's client Biosimilar Solutions, Inc., announces it has started its registrational clinical trials for the biosimilar version...
OcyonBio Client Biosimilar Solutions, Inc. Initiates Registrational Clinical Trial for Its First Biosimilar Product
23 mars 2022 12h00 HE
|
OcyonBio (ocyonbio.com)
AGUADILLA, Puerto Rico, March 23, 2022 (GLOBE NEWSWIRE) -- Biosimilar Solutions, Inc. announces it has started its registrational clinical trials for BSC1020®, a recombinant filgrastim product...
OcyonBio Announces Biosimilar Solutions to Begin GMP Manufacturing in Puerto Rico
14 mars 2022 11h46 HE
|
OcyonBio (ocyonbio.com)
AGUADILLA, Puerto Rico, March 14, 2022 (GLOBE NEWSWIRE) -- OcyonBio announces manufacturing and operations agreement to develop biosimilar drug product facilities for Biosimilar Solutions, Inc....